These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12923675)

  • 21. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL; Lladó Plarrumaní A
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain.
    Xing GG; Liu FY; Qu XX; Han JS; Wan Y
    Exp Neurol; 2007 Dec; 208(2):323-32. PubMed ID: 17936754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
    Christoph T; Schiene K; Englberger W; Parsons CG; Chizh BA
    Neuropharmacology; 2006 Jul; 51(1):12-7. PubMed ID: 16616769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat.
    Jang JH; Kim DW; Sang Nam T; Se Paik K; Leem JW
    Neuroscience; 2004; 128(1):169-76. PubMed ID: 15450364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapy for neuropathic pain.
    Mizoguchi H; Watanabe C; Yonezawa A; Sakurada S
    Int Rev Neurobiol; 2009; 85():249-60. PubMed ID: 19607975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
    Gogas KR
    Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A; Alfaro V
    Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article.
    Chizh BA
    Amino Acids; 2002; 23(1-3):169-76. PubMed ID: 12373533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stump pain relieved by continuous intravenous ketamine infusion therapy].
    Mizuno J; Sugimoto S; Ohmori T; Itadera E; Ichikawa N; Machida K
    Masui; 2001 Jul; 50(7):770-2. PubMed ID: 11510069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side effects of ketamine in the long-term treatment of neuropathic pain.
    Cvrcek P
    Pain Med; 2008 Mar; 9(2):253-7. PubMed ID: 18298710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a peripheral NMDA receptor antagonist on glutamate-evoked masseter muscle pain and mechanical sensitization in women.
    Castrillon EE; Cairns BE; Ernberg M; Wang K; Sessle BJ; Arendt-Nielsen L; Svensson P
    J Orofac Pain; 2007; 21(3):216-24. PubMed ID: 17717960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine for the treatment of general neuropathic pain: a narrative review.
    Pickering G; Morel V
    Fundam Clin Pharmacol; 2018 Feb; 32(1):4-13. PubMed ID: 28802070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic drugs in the treatment of neuropathic pain.
    Attal N
    Expert Rev Neurother; 2001 Nov; 1(2):199-206. PubMed ID: 19811032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
    Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
    Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of NMDA-receptor antagonists in the treatment of chronic pain.
    Hewitt DJ
    Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 40. Memantine, an uncompetitive low affinity NMDA open-channel antagonist improves clinical rating scores in a multiple infarct embolic stroke model in rabbits.
    Lapchak PA
    Brain Res; 2006 May; 1088(1):141-7. PubMed ID: 16626666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.